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ORIGINAL ARTICLE
Development and feasibility of the Help to Overcome Problems Effectively (HOPE)
self-management intervention for people living with multiple sclerosis
Joanna K. Anderson, Andy Turner and Wendy Clyne
Centre for Technology Enabled Health Research, Coventry University, Coventry, UK
ABSTRACT
Purpose: To describe the development and feasibility of a self-management intervention called the Help
to Overcome Problems Effectively (HOPE: MS), aimed at improving the physical and psychological well-
being of people living with Multiple Sclerosis (MS).
Method: HOPE: MS is an innovative, 6-week group-based, manualised self-management intervention com-
bining positive psychology theory and practice, and cognitive behavioural therapy (CBT). Participants
(N¼ 21) recruited via a local East Midlands branch of the MS Society attended one of three HOPE: MS
interventions and completed self-reported outcome measures in week 1 and week 6. The following out-
come measures were used: The Multiple Sclerosis Impact Scale; Multiple Sclerosis Fatigue Severity Scale;
The Multiple Sclerosis Self-Efficacy Scale; The Adult State Hope Scale; The Hospital Anxiety and Depression
Scale; The Positive and Negative Affect Scale.
Results: Post-intervention (6 weeks) mean scores decreased in the physical impact (baseline M¼ 65.6,
SD¼ 17.4; 6 weeks M¼ 55.1, SD¼ 17.9, 95% CI ["4.39, "16.47] and the psychological impact of MS (base-
line M¼ 24.0, SD¼ 7.3; 6 weeks M¼ 18.9; SD¼ 6.3, 95% CI ["2.54, "7.66]). There was also a decrease
mean fatigue severity scores (baseline 49.4, SD¼ 13.3, 6 weeks M¼ 41.1, SD¼ 14.4, 95% CI ["2.65,
"13.44]). There was a mean decrease in depression scores (baseline M¼ 6.9, SD¼ 3.5; 6 weeks M¼ 4.2,
SD¼ 2.8, 95% CI ["1.43, "4.00]). There were smaller mean decreases in anxiety (baseline M¼ 7.6, SD¼ 3.4;
6 weeks M¼ 6.7 (4.0), 95% CI [0.69, "2.50]) and negative affect (baseline M¼ 22.9, SD¼ 6.8; 6 weeks
M¼ 20.8 (8.1), 95% CI [0.69, "2.50]) refer Table 3). Mean MS self-efficacy scores (baseline 21.7, SD¼ 4.2; 6
weeks M¼ 24.1, SD¼ 4.7, 95% CI [0.23, 4.53]), mean total hope scores (baseline M¼ 23.3, SD¼ 10.7; 6
weeks M¼ 32.2 (10.6), 95% CI [4.91, 12.9]), hope agency scores (baseline M¼ 10.5, SD¼ 5.7; 6 weeks
M¼ 15.7 (6.2), 95% CI [2.37, 8.01]), hope pathways (baseline M¼ 12.9, SD¼ 6.0; 6 weeks M¼ 16.6 (4.9),
95% CI [2.00, 5.43]) and positive affect scores increased (baseline M¼ 27.3, SD¼ 7.1; 6 months M¼ 32.2,
SD¼ 8.4, 95% CI [0.42, 9.39]). Participants positively rated the intervention quality and delivery.
Conclusions: This feasibility study showed that the HOPE: MS was acceptable and useful to people living
with MS. Further robust evaluations using a randomised controlled trial design with longer follow ups are
needed to confirm early promising results of the HOPE: MS.
! IMPLICATIONS FOR REHABILITATION
# Living with MS requires constant adjustments to cope with unpredictable symptoms.
# Self-management interventions have the potential to help people living with MS to improve their qual-
ity of life.
# A feasibility study of the HOPE: MS self-management group-based intervention showed that it was
acceptable and useful to people living with MS.
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Introduction
Multiple sclerosis (MS) is a chronic, progressive and currently
incurable disease of the central nervous system, characterised by
autoimmune inflammation, demyelination and axonal damage.[1]
MS aetiology remains unknown, however an interaction between
complex genetic factors and environmental influences seems to
play a major role.[1] It is estimated that MS affects more than 2
million people worldwide [2] and approximately 127,000 adults in
the UK,[3] and is the most common cause of neurological disability
among young adults. MS symptom experience and symptom
severity vary, depending upon the area of the brain in which
lesions occur, thus no two cases of MS are exactly alike. Patients
with relapsing-remitting MS after relatively symptom free periods
experience flare-ups which duration and severity is highly unpre-
dictable, while in secondary progressive MS the disease progresses
continuously without remission.[1]
The most common MS symptoms include spasticity, weakness,
tremor, balance and mobility problems, bladder and bowel dys-
functions, sexual dysfunctions, speech difficulties, swallowing
difficulties and cognitive impairment.[4] The majority of people liv-
ing with MS also experience severe fatigue [5] and depression.[6]
It is estimated that up to 55% of people living with MS experience
major depression in their lifetime.[7] Depression in MS has been
CONTACT Prof Andy Turner a.turner@coventry.ac.uk Centre for Technology Enabled Health Research, Coventry University, Priory Street, Coventry CV1 5FB, UK
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associated with breakdowns in interpersonal relationships and
employment, cognitive impairment, decreased adherence to treat-
ment and greater suicide risk.[7]
Living with MS requires constant adjustments and the develop-
ment of strategies to effectively cope with a wide array of
unpredictable symptoms of the disease to maintain best possible
health and quality of life.[8] The US Institute of Medicine describes
self-management as ‘‘the tasks that individuals must undertake to
live with one or more chronic conditions. These tasks include hav-
ing the confidence to deal with medical management, role man-
agement and emotional management of their conditions’’.[9]
Some of the main self-management skills include problem solving,
decision making, resource utilisation, formation of a patient-pro-
vider partnership, action planning and goal-setting.[10]
As indicated in a report by the Consortium of Multiple Sclerosis
Centres [11] participation in self-management support interven-
tions is particularly important for people with MS. There is a large
evidence base showing that MS self-management interventions
underpinned by cognitive-behavioural approaches are effective in
reducing depression,[7,12–15] stress,[5,16–19] perceived severity
and impact of MS symptoms including fatigue and pain [20–22]
and improving quality of life in people with MS.[23]
The aim of this feasibility study was to evaluate the acceptabil-
ity and usefulness of a self-management intervention called the
Help to Overcome Problems Effectively (HOPE: MS) intervention in
improving the physical and psychological wellbeing of people
living with MS.
HOPE: MS intervention underpinning theory
HOPE: MS is underpinned by positive psychology theory and
research. We pursued this innovative approach to developing
HOPE: MS because our evaluations of self-management interven-
tions for other long term conditions identified a renewed sense of
hope, a striving to use personal strengths in the pursuit of living
well.[24–26] Positive psychology is concerned with the full range
of human functioning and has the dual aims of alleviating psycho-
logical distress and promoting positive well-being. Professor Martin
Seligman is attributed as responsible for officially launching posi-
tive psychology as a scientific endeavour during his American
Psychological Association Presidential Lecture in 1998. However, as
many others have noted, applied positive psychology has a
research tradition which spans decades. Linley and Joseph [27]
point out that cognitive behavioural therapy have a long tradition
of using positive psychological techniques. Lopez et al. [28] have
described the potential usefulness of positive psychology to com-
plement CBT because of the shared focus on a strengths approach
to adjustment and development of the two approaches. Karwoski
et al. [29] suggest that there is considerable conceptual and tech-
nical overlap between CBT and positive psychological approaches
including developing a strong therapeutic relationship between cli-
ent and therapist/coach; focusing on goals; cognitive reappraisal/
mindfulness; scheduling pleasant activities; identifying and review-
ing successes; monitoring mood; relaxation training and problem
solving.
Snyder’s hope theory [30] and Fredrickson’s Broaden and Build
theory [31] underpin HOPE: MS. Although hope theory is similar to
self-efficacy theory, there are important differences.[32] Whereas
self-efficacy theory focuses on specific goals and behaviours, hope
theory recognises enduring cross-situational goals and behaviours,
and is therefore highly relevant to the broader task of managing
the diverse impact of living with a long term condition. Further,
self-efficacy theory emphasises the role of agency beliefs, whereas
hope theory proposes a cognitive set that includes both agency
(goal directed determination) and pathways (planning of ways to
meet goals).[32] Hope has been conceptualised and defined as
‘‘cognitive set that is based on a reciprocally-derived sense of suc-
cessful agency (goal-directed determination) and pathways (plan-
ning to meet goals)’’.[32] As can be seen from Snyder’s definition,
goals are fundamental to hope theory. Pathway thoughts describe
the perceived ability to produce plausible routes to goals, whereas
agency thought is the motivational element, which focuses on
commencing and persevering with goal pursuits. Pathway and
agency thoughts are iterative and additive.[32]
A distinct feature of HOPE is a focus on an upward spiral of
positive emotions [31] and experiences leading to greater well-
being, resilience and coping. This contrasts with the more com-
mon approach used in other self-management interventions (e.g.
the Expert Patient Programme [33]) that introduce a negative spi-
ral of fear and frustration leading to negative health and well-
being. Fredrickson (1998) suggests that increasing positive
emotions and states is an efficient and often preferable approach
to reducing negative emotions.[31] Fredrickson’s broaden and
build theory (1998) [31] suggests that positive emotions broaden
an individual’s attention, thinking and action thus enabling the
building of new, creative thought and action pathways (i.e.
expanding an individual’s coping skills) and the building of per-
sonal and social resources.
There is a growing body of evidence that suggests that grati-
tude improves psychological well-being and increases positive
emotions.[34,35] There have been a number of studies that have
shown that interventions that increase gratitude are a promising
Table 1. HOPE: MS intervention content.
Session number Session Activities
Session 1 Welcome, introduction and ground rules
What is self-management?
Instilling hope: The upward spiral of positivity
Diaphragmatic breathing
Gratitude diary
Goal setting and action planning
Session 2 Welcome and reflections from last week’s session
Solution focused goal feedback
Gratitude diary
Managing stress
Introduction to mindfulness
Goal setting and action planning
Session 3 Welcome and reflections from last week’s session
Solution focused goal feedback
Gratitude diary
Managing fatigue
Managing emotions
Guided imagery
Goal setting and action planning
Session 4 Welcome and reflections from last week’s session
Solution focused goal feedback
Gratitude diary
Body image, sexuality and intimacy
Communication
Goal setting and action planning
Welcome and reflections from last week’s session
Session 5 Solution focused goal feedback
Gratitude diary
Fear of relapse and disease progression
Move and feel good
Goal setting and action planning
Session 6 Welcome and reflections from last week’s session
Solution focused goal feedback
Gratitude diary
Character strengths
Life priorities
Motivational imagery
Sharing successes
Moving on and staying in touch
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clinical intervention for improving psychological well-being, but
perhaps most significantly, depression.[36] There have been calls
for further research into gratitude interventions as they could be
more widely used in clinical settings.[38] A gratitude activity is a
weekly feature in the HOPE: MS intervention. It is designed to
increase participants’ positive emotions. HOPE: MS also includes
other evidence-based CBT and positive psychological activities
such as identifying personal strengths, scheduling pleasant activ-
ities, mindfulness, relaxation training and reviewing successes.[29]
Refer Table 1 for HOPE: MS weekly content.
HOPE: MS utilises Irvin Yalom’s (2005) group curative factors,
including instillation of hope, universality (realising you are not
alone) and altruism.[37] Participants observe each other and the
facilitators successfully overcoming the challenges of living with
MS through achieving their weekly goals (instillation of hope),
share common experiences (universality) and are encouraged to
support each other through the provision of informational and
emotional support (altruism).
Development of the HOPE: MS intervention
The HOPE: MS was developed with funding from the MS Society
through their Small Grants Innovation Award Scheme. The MS
Society is a UK charity providing information and support for peo-
ple living with MS. Development and feasibility testing of HOPE:
MS was guided by the MRC framework for developing and testing
complex intervention [38] and involved consultations with MS
health professionals and people living with MS. HOPE: MS is a
group-based self-management intervention delivered in six weekly
sessions each of 2.5 h duration. Two HOPE: MS interventions were
delivered to 14 participants in total and feedback was obtained
from five participants and three facilitators via focus groups and
interviews about how to improve the process and content of the
intervention. HOPE: MS was found to be acceptable in terms of
format, content and delivery. Participants and facilitators men-
tioned that the most valued aspects of the intervention were goal
setting and action planning, deep breathing exercises and sharing
and learning with similar others. For some participants, the HOPE:
MS intervention allowed them to be more positive about living
with MS, particularly in terms of encouraging them to think about
their strengths. Participants valued having the opportunity to share
and learn with similar others. Participants felt supported and
understood by the facilitators who had experienced and overcame
similar challenges. Several changes were made to the intervention
on the basis of this formative evaluation, including a more com-
prehensive and MS specific physical activity and fatigue manage-
ment component, and the addition of an ‘‘open space forum’’
session in week 6. The focus of the ‘‘open space forum’’ would be
selected by the group and could address any specific concerns the
group had which had not been covered in the intervention cur-
riculum. Invited speakers could also contribute to this session.
Other changes made to the intervention included using more
interactive learning materials and activities such as information
and educational videos (e.g. ‘‘The Science of Character’’; https://
www.youtube.com/watch?v¼U3nT2KDAGOc) quizzes, fatigue and
pacing diaries, physical activity case studies and communication
skills role playing) in the intervention delivery.
HOPE: MS content and delivery
Two people living with MS who had previous experience of deliv-
ering self-management interventions for the MS Society in the UK
were recruited to deliver the HOPE: MS. Each session follows a
similar pattern. There is a combination of psycho-education, skills
practice, in-depth group discussion and setting and reviewing
goals Participants set personally relevant and meaningful weekly
goals, as ‘‘homework’’ tasks which they were invited to share with
other group members and provide goal attainment or goal barrier
feedback the following week. Goal setting and action planning are
key behaviour change techniques that have a strong evidence
base.[39,40] Other ‘‘homework’’ tasks include completing a fatigue
and pacing diary and taking an online character strengths test.
HOPE: MS facilitator training
Facilitator training encompasses a 2-day classroom-based training
course. The classroom training involves training in motivational
interviewing (e.g. reflective listening) and behaviour change skills
(e.g. goal setting, action planning), group facilitation skills (e.g.
managing challenging behaviours) and delivery practice of inter-
vention activities. Delivery is guided by a tutor’s manual to ensure
consistency of delivery and content. Facilitators were trained and
accredited against a rigorous set of quality standards with training
and intervention delivery focusing on adherence to the timing,
sequence and coverage of activities as set out in the manual to
ensure fidelity. Facilitators were observed delivering a session from
the first HOPE: MS intervention and assessed using a fidelity check-
list. Ongoing support was provided by one of the authors (AT) and
the lead HOPE facilitator trainer, both of whom are experienced
self-management trainers, having trained over 500 peer and pro-
fessional facilitators.
Feasibility study
Participants were recruited via a local East Midlands branch of the
MS Society at drop in sessions and the branch’s annual confer-
ence. People living with MS were informed that the intervention
would provide the opportunity to learn how to better manage
their MS and to meet other people living with MS in a supportive
group setting. In total, 25 people living with MS expressed an
interest in attending the intervention and provided contact details.
Four participants subsequently decided not to participate, because
the timing of the intervention was inconvenient due to either holi-
day (N¼ 1) or work commitments (N¼ 1) or feeling unwell (N¼ 2).
The following inclusion/exclusion criteria were established:
Inclusion criteria:
# Diagnosis of any type of MS confirmed by neurologist.
# Aged 18 years and over.
# Ability to complete a questionnaire.
Exclusion criteria:
# Inability to understand and participate in an intervention
delivered in English.
# Current participation in any other research study.
Procedure
Three HOPE interventions were delivered sequentially over a
12-month period. No changes were made to the intervention dur-
ing this period. Participants completed outcome measures during
session one (baseline) and session six (post-intervention). A self-
management intervention quality and delivery rating scale was
completed during the last session of the intervention.
Outcome measures
Demographic information such as age, gender, ethnicity, type of
MS and co-morbidity, was collected at baseline only (refer Table 2
for demographic variables). We used a range of outcome measures
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selected to best capture self-management outcomes relevant for
people living with MS.
The Multiple Sclerosis Impact Scale (MSIS-29) [41] has 29 items;
21 relating to the physical impact of the condition (e.g. difficulties
moving about indoors) and eight relating to psychological impact
(e.g. feeling anxious or tense). The timeframe for completion is ‘‘in
the previous two weeks’’ and each item is rated on a scale anch-
ored at 1 (not at all) and 5 (extremely). Scores for physical and
psychological impact are summed separately with higher scores
indicating greater physical and psychological limitations.
The Multiple Sclerosis Fatigue Severity Scale [42] contains nine
items relating to fatigue within the previous week with each item
rated on a scale anchored at 1 (strongly disagree) and 7 (strongly
agree) with higher scores indicating higher levels of fatigue.
Example items include: Fatigue interferes with my physical function-
ing; Fatigue causes frequent problems for me.
The Multiple Sclerosis Self-Efficacy Scale [43] was used to deter-
mine the level of self-efficacy (confidence) each participant had in
the previous week. Each of the 11 items is rated 1 (strongly agree)
to 4 (strongly disagree); higher scores reflect greater self-efficacy.
Example items include: Despite my difficulties, I still manage to cope
with daily life; I am confident I can overcome my difficulties.
The Hospital Anxiety and Depression Scale (HADS) [30] com-
prises 14 items; seven assessing anxiety (e.g. Worrying thoughts go
through my mind) and seven assessing depression (e.g. I look for-
ward with enjoyment to things). Each item is rated 0–3; anxiety and
depression scores are summed separately. Scores range from 0–21;
higher scores indicate higher anxiety and depression.
The Positive and Negative Affect Scale (PANAS) [44] assesses
positive and negative effect. The scale comprises 20 words, 10
describing positive affect (e.g. interested, excited) and 10 describing
negative affect (e.g. upset, guilty). Each word is rated 1(very slightly
or not at all) to 5 (extremely) indicating to what extent the partici-
pant had felt each emotion in the previous week. Scores for posi-
tive affect and negative affect are summed separately; higher
scores indicate higher levels of positive and negative effect.
The Adult State Hope Scale [45] measures hope defined as the
perceived ‘‘capability to derive pathways to desired goals, and
motivate oneself via agency thinking to use those pathways’’.[34]
The scale comprises six statements which represent pathways (e.g.
There are lots of ways around any problem that I am facing now)
and agency (e.g. At the present time, I am energetically pursuing my
goals) beliefs. Participants indicate the extent to which they agree
with each of the six statements on scale anchored at 1 (definitely
false) and 8 (definitely true). Overall scores range from 6 to 48
with higher scores indicting higher levels of hopeful thinking.
Scores for the Agency and Pathways subscale items are summed
separately to provide scores between 3 and 24, with higher scores
indicating more agency and pathways beliefs.
Intervention quality and delivery rating scale
The Health Education Impact Questionnaire (heiq) is a nine items
scale [46] which assesses self-management intervention quality,
and has been used to evaluate self-management interventions in
the UK [47] and Australia.[46] Participants completed the heiq
scale during the last session of the intervention. Responses to
each of the nine items are scored: 1¼ Strongly Disagree,
2¼Disagree, 3¼Agee, 4¼ Strongly Agree. Higher scores indicate
more positive feedback. Scores are averaged to provide a mean
score for each item between 1 and 4. Example items include: ‘‘I
intend to tell other people that the intervention is very worth-
while’’.; ‘‘The content was very relevant to my situation’’.
The study was approved by Coventry University Ethics
Committee.
Data analysis
All data analyses were conducted using IBM SPSS Statistics version
20 (IBM Corporation, Armonk, NY). Descriptive statistics, mean (SD)
and 95% CI are presented for baseline and post-intervention out-
comes in keeping with studies with small sample sizes, which are
not adequately powered for hypothesis testing.[48]
Results
All 21 participants completed the intervention (17 participants
attended all 6 sessions; 2 attended 5 sessions and 2 attended 4
sessions) and completed baseline and post-intervention outcome
measures.
Demographic variables
All the respondents were of White ethnic origin and a majority
were women (81%, n¼ 17). Participants mean age was 54.3 years
(SD 10.5 years; age range 36–76 years). Twelve respondents had
relapsing-remitting MS, eight secondary progressive MS and one
participant had benign MS. Just under half of respondents (43%,
n¼ 9) had a co-morbid health condition in addition to MS.
Participants’ characteristics are summarised in Table 2.
Outcomes
Participation in HOPE: MS was associated with improvements in all
MS-specific outcome measures. Table 3 shows that at the end of
the 6-week intervention mean scores decreased in both the phys-
ical impact (baseline M¼ 65.6, SD¼ 17.4; 6 weeks M¼ 55.1,
SD¼ 17.9, 95% CI ["4.39, "16.47]) and the psychological impact
of MS (baseline M¼ 24.0, SD¼ 7.3; 6 weeks M¼ 18.9; SD¼ 6.3,
95% CI ["2.54, "7.66]), as measured by MSIS-29. There was also a
decrease in mean fatigue severity scores (baseline 49.4, SD¼ 13.3,
6 weeks M¼ 41.1, SD¼ 14.4, 95% CI ["2.65, "13.44]) and mean
MS self-efficacy scores increased (baseline 21.7, SD¼ 4.2; 6 weeks
M¼ 24.1, SD¼ 4.7, 95% CI [0.23, 4.53]).
Participation in HOPE:MS was also associated with a mean
decrease in depression scores (baseline M¼ 6.9, SD¼ 3.5; 6 weeks
M¼ 4.2, SD¼ 2.8, 95% CI ["1.43, "4.00]), increase in mean total
hope scores (baseline M¼ 23.3, SD¼ 10.7; 6 weeks M¼ 32.2 (10.6),
95% CI [4.91, 12.9]), hope agency scores (baseline M¼ 10.5,
SD¼ 5.7; 6 weeks M¼ 15.7 (6.2), 95% CI [2.37, 8.01)], hope path-
ways (baseline M¼ 12.9, SD¼ 6.0; 6 weeks M¼ 16.6 (4.9), 95% CI
[2.00, 5.43] and positive affect (baseline M¼ 27.3, SD¼ 7.1; 6
months M¼ 32.2, SD¼ 8.4, 95% CI [0.42, 9.39]). There were smaller
mean decreases in anxiety (baseline M¼ 7.6, SD¼ 3.4; 6 weeks
M¼ 6.7 (4.0), 95% CI [0.69, "2.50]) and negative affect (baseline
Table 2. Demographic characteristics of participants.
Characteristics N Mean (SD)
Age: Mean (SD¼ standard deviation, range) 21 54.3 (10.5) (36–76)
%
Gender
Male 4 19
Female 17 81
Ethnic origin
White 21 100
Type of MS
Relapsing-remitting 12 57.1
Secondary progressive 8 38.1
Benign 1 4.8
Co-morbidity 9 43
4 J. K. ANDERSON ET AL.
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M¼ 22.9, SD¼ 6.8; 6 weeks M¼ 20.8 (8.1), 95% CI [0.69, "2.50];
Table 3).
Course quality and delivery
Table 4 shows that the mean ratings for all nine items was 3.6 or
above, indicating that participants rated the HOPE intervention
delivery and quality positively.
Discussion
To the best of our knowledge, this is the first study to look at
whether a self-management intervention developed combining
positive psychology and CBT theory and practice is acceptable,
and if it has the potential to be useful for people living with MS.
All the 21 participants completed pre and post-intervention out-
come measures and attended at least four sessions, which indi-
cates the intervention is acceptable for people living with MS. The
outcome measures reflected important aspects of living with MS
including fatigue, anxiety, depression and physical limitations. In
keeping with the positive psychological theory underpinning the
intervention, we also used outcome measures which assessed posi-
tive affect and hope. Mean scores on all of the outcome measures
improved and these improvements are in line with other feasibility
trials we have conducted with HOPE interventions for cancer survi-
vors [49] people living with HIV [50] and parent caregivers
[N¼ 54].[51] The scale of the improvements are also consistent
with randomised controlled trials of self-management interventions
for people living with a range of long-term conditions, of a similar
duration (6 weeks) delivered by peer facilitators.[33,44,52]
Positive psychology interventions should address illnesses that
affect longevity, cause disability, have variable prognosis and can
involve relapse.[53] Recently, self-management researchers have
emphasised the importance of fostering hope and other positive
psychological and emotional states in supporting people to man-
age their condition.[54,55]
Interventions such as HOPE: MS that have the potential to
reduce depression associated with MS can potentially prevent the
development of severe mood disorders, help reduce demand
placed on psychological services and reduce healthcare costs.
Several hope therapy based studies [56,57] involving older
depressed adults in the US reported a statistically significant
increase and large effect size improvement in hope and reduced
feelings of hopelessness, anxiety and depression.
Chronic fatigue is considered by people affected by MS to be
the most debilitating symptom and leads to most disruption in
their everyday activities.[58] Improved self-management of fatigue
can enable people living with MS to lead a more active life and as
a result significantly improve patients’ quality of life. MS self-effi-
cacy, positive affect and hope scores all improved. Studies show
that MS self-efficacy is an important predicator of self-reported
physical, social and cognitive functioning in MS and plays a signifi-
cant role in individual psychological adjustments to MS.[59] The
improvements in positive affect and hope are important as they
reflect the positive psychological theoretical underpinnings of
HOPE: MS. High positive affect refers to a general tendency to
experience a ‘‘state of high energy, full concentration and pleasur-
able engagement’’.[45] We have described elsewhere the import-
ant role positive emotions have among participants attending self-
management interventions in helping them to cope.[60] Moreover,
focusing on positives is one of the predicators of better psycho-
logical adjustment to MS, higher levels of energy and reduced
fatigue.[13] MS is often associated with loss of hope that can lead
to depression.[12] Hope (goal directed agency and planning) has
been shown to be a unique predictor of general wellbeing.[61]
Mean changes in anxiety and negative affect were smaller than
the other outcomes. In an evaluation of an arthritis self-manage-
ment intervention, we reported improvements in positive affect
but not negative effect, at 12 months, similar to the results of this
study.[62] Women with MS are particularly prone to anxiety disor-
ders,[63] and since our sample included mostly females, we may
speculate that they were more likely to experience some form of
anxiety. Many studies have assessed the effectiveness of different
kinds of interventions in reducing depression in people living with
MS,[7] however studies examining the effectiveness of interven-
tions in reducing anxiety are scarce thus it is difficult to speculate
why mean improvements in anxiety scores were not similar to
other outcome measures. Further studies are needed to determine
Table 4. Participants’ rating of intervention quality and deliver rating (mean, SD).
Self-management intervention quality report items Mean (SD)
I intend to tell other people that the intervention is very worthwhile 3.7 (4.6)
The intervention has helped me set goals that are reasonable & within reach 3.6 (0.5)
I trust the information and advice obtained from programme 3.7 (0.5)
Intervention tutors very well organised 3.6 (0.6)
I feel it was worth my time and effort to take part 3.8 (0.4)
Difficult topics and discussions were handled well by tutors 3.8 (0.4)
Content was very relevant to my situation 3.7 (0.6)
I feel that everyone in the intervention had the chance to speak if they wanted 3.9 (0.3)
The people in the group worked very well together 4.0 (0.0)
Table 3. Changes in outcome measure scores (mean, (SD) [95% CI]) pre- and 6 weeks post-HOPE: MS intervention.
Measure Mean (SD) baseline Mean (SD) 6 weeks 95% CI
MSIS: Physical (21–105, # ¼ better) 65.6 (17.4) 55.1 (17.9) ["4.39, "16.47]
MSIS: Psychological (8–40, # ¼ better) 24.0 (7.3) 18.9 (6.3) ["2.54, "7.66]
MS: Fatigue Severity (9–63, # ¼ better) 49.4 (13.3) 41.4 (14.4) ["2.65, "13.44]
MS: Self-Efficacy (11–44," ¼ better) 21.7 (4.2) 24.1 (4.7) [0.23, 4.53]
HADS: Anxiety (0–21, # ¼ better) 7.6 (3.4) 6.7 (4.0) [0.69, "2.50]
HADS: Depression (0–21, # ¼ better) 6.9 (3.5) 4.2 (2.8) ["1.43, "4.00]
PANAS: Positive effect (10–50, " ¼ better) 27.3 (7.1) 32.2 (8.4) [0.42, 9.39]
PANAS: Negative effect (10–50,# ¼ better) 22.9 (6.8) 20.8 (8.1) [0.77, "4.87]
HOPE total score (6–48, " ¼ better) 23.3 (10.7) 32.2 (10.6) [4.91, 12.9]
HOPE subscale: agency 10.5 (5.7) 15.7 (6.2) [2.37, 8.01]
HOPE subscale: pathways 12.9 (6.0) 16.6 (4.9) [2.00, 5.43]
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what self-management interventions components are associated
with lower anxiety.
The results of the heiq intervention quality and delivery report
are positive and suggest that overall participants are satisfied with
the quality of the programme, the delivery style and skills of the
tutors. These results are similar to those reported by a large scale
UK evaluation of a similar type of peer led self-management
intervention.[46]
Limitations
The mean differences between pre and post-course scores were
generally high, which is promising, but need to be interpreted
with caution for several reasons. The study had a small sample
size, and was uncontrolled. Only baseline and post intervention
data were collected so we are unable to say whether the improve-
ments are maintained in the longer term. The sample was self-
selected, highly motivated and homogenous, with all participants
being of White ethnic origin and the majority were women. It is
possible that this self-selected group have a natural inclination to
respond favourably to a positive psychological approach to man-
aging their MS.
Post-intervention outcomes were collected during the last ses-
sion in the presence of the facilitators, which introduces the risk of
bias as participants may experience the Hawthorne effect [64] and
give overly positive outcome scores. Further, the response time for
some of the outcome measures meant that participants based
their responses on a period before the intervention ended (e.g.
PANAS, previous week, MSIS-29, previous 2 weeks). Finally, we did
not collect any information about disease duration or level of
disability.
An adequately powered, randomised controlled trial is needed
to establish whether HOPE: MS has the potential to provide longer
term positive effects and whether it is acceptable and useful in
the long-term (6–12 months follow up). The sample should include
participants of different ethnic origins, different types of MS,
including those with primary progressive MS and men.
Conclusion
HOPE: MS is an innovative self-management intervention combin-
ing positive psychology theory and practice, and CBT. The inter-
vention was acceptable and useful for people living with MS, and
the quality of delivery was positively rated. Further robust evi-
dence is needed of the impact of the HOPE: MS self-management
intervention.
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